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QSARAbstract A series of p-coumaric acid derivatives (1–36) was synthesized and characterized by phys-
icochemical as well as spectral means. The synthesized compounds were evaluated in vitro for their
antimicrobial activity against different Gram positive and Gram negative bacterial and fungal
strains by the tube dilution method. Results of antimicrobial screening indicated that compound
17 was the most active antimicrobial agent (pMICam = 1.73 lM/mL). The results of QSAR studies
demonstrated that antibacterial, antifungal and overall antimicrobial activities of synthesized
p-coumaric acid derivatives were governed by the electronic parameter, electronic energy (Ee)
and topological parameters ﬁrst order molecular connectivity index (1v) and Wiener index (W).
ª 2014 Production and hosting by Elsevier B.V. on behalf of King Saud University.1. Introduction
In an era of increasing bacterial resistance to classical antibac-
terial agents, it has been postulated that the development of
resistance to known antibiotics could be overcome by identify-
ing new drug targets via genomic, improving existing antibiot-
ics and most importantly by identifying new antibacterial
agents with novel structures and mode of action. This will
always remain the primary goal (Salahuddin et al., 2009).
The antimicrobial potential of simple organic acids is well
established in the literature viz. sorbic acid (Narasimhan
et al., 2003), cinnamic acid (Narasimhan et al., 2004), anacar-
dic acid (Narasimhan and Dhake, 2006a), veratric acid(Narasimhan et al., 2009), myristic acid (Narasimhan et al.,
2006b), caprylic acid (Chaudhary et al., 2008), anthranilic acid
(Mahiwal et al., 2012) and dodecanoic acid (Sarova et al.,
2011). Literature reports reveal that the p-coumaric acid and
its derivatives possess a wide spectrum of biological activities
like antimicrobial (Proestos et al., 2006), antioxidant (Caia
et al., 2004), anti-platelet (Luceri et al., 2007), anti-infertility
(Kumar et al., 2012a), anti-tyrosinase (Lim et al., 1999) and
antiviral (Stankova et al., 2009).
The QSAR (quantitative structure–activity relationship)
referred to statistical analysis of potential relationships between
chemical structures and biological activity. QSAR is essentially
a computerized statistical method which tries to explain the
observed variance in the biological effect of certain classes
of compounds as a function of molecular changes caused by
the substituents. These physicochemical descriptors, which
included parameters to account for hydrophobicity, electronic
properties, and steric effect, are determined empirically or,
more recently, by computational methods (Sahu et al., 2013).
In light of above mentioned facts and in continuation of
our research efforts in the ﬁeld of synthesis, antimicrobialvatives.
2 A. Khatkar et al.evaluation and QSAR studies (Sigroha et al., 2012; Kumar
et al., 2010, 2012a,b; Judge et al., 2012a,b, Narang et al.,
2012a,b), we hereby report the synthesis, antimicrobial evalu-
ation and QSAR studies of p-coumaric acid derivatives.2. Materials and methods
All reagents and solvents used in the study were of analytical
grade and procured locally. The progress of the reaction was
monitored by TLC (Thin Layer Chromatography) and
products were puriﬁed through recrystallization and purity
of the compounds was checked by TLC performed (Nuclear
Magnetic Resonance) on silica gel G coated plate. The spectral
studies, IR (Infrared Spectroscopy) and 1H NMR were deter-
mined by standard methods. IR spectra were recorded on a
FTIR Bruker ATR instrument and were recorded in cm1.
1H NMR spectra were recorded in DMSO-d6 on a Bruker
DRX-300 FTNMR instrument. Elemental analysis was per-
formed on a Perkin–Elmer 2400 C, H, N analyzer.HO
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p-coumaric acid
The solution of corresponding amine/aniline (0.1 mol) in ether
(50 mL) was added dropwise to a solution of p-coumaric acid
chloride (0.1 mol) in ether (50 mL) maintained at 0–10 C
temperature. The solution was stirred for 30 min and the pre-
cipitated amide was separated by ﬁltration. The crude amide
was recrystallized with alcohol. In case of anilides, the precip-
itated crude anilide was treated with 5% hydrochloric acid,
4% sodium carbonate and water to remove residual aniline
and the resultant anilide was recrystallized with alcohol.
2.2. General procedure for the synthesis of esters of p-coumaric
acid (1, 11, 17–22, 25–26)
For the preparation of p-coumaric acid chloride, thionyl
chloride (0.3 mol) was added gradually to p-coumaric acid
(0.25 mol) in a round bottom ﬂask. After addition of thionylCOOH R-OH
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Synthesis, antimicrobial evaluation and QSAR studies of p-coumaric acid derivatives 3chloride, the mixture was stirred for 4 h and heated to 80 C
for 30 min in a water bath. The excess of thionyl chloride
was removed by distillation. A solution of 8-hydroxy quinoline
(0.05 mol) in ether (50 mL) was added to a solution of p-cou-
maric acid (0.05 mol) in ether (50 mL). The mixture was heated
on a water bath until no further evolution of hydrogen chlo-
ride was observed and completion of reaction was checked
by single spot TLC. The mixture was cooled to room temper-
ature and evaporation of solvent yielded the crude product
which was puriﬁed by recrystallization with alcohol.
2.3. General procedure for the synthesis of esters of p-coumaric
acid (10, 23 and 24)
A mixture of p-coumaric acid (0.08 mol) and appropriate alco-
hol (0.74 mol) was heated under reﬂux in the presence of sul-
phuric acid till the completion of reaction which was checked
by single spot TLC. Then, the reaction mixture was poured
in 200 mL ice cold water, neutralized with sodium bicarbonate
solution followed by extraction of ester with ether (50 mL).
The ether layer was separated, which on evaporation yielded
the ester derivatives of p-coumaric acid.
2.4. In vitro antimicrobial activity
The antimicrobial activity of the synthesized compounds was
tested against Gram-positive bacteria: Staphylococcus aureus
MTCC 2901, Bacillus subtilis MTCC 2063, Gram negative
bacterium: Escherichia coli MTCC 1652 and fungal strains:
Candida albicans MTCC 227 and Aspergillus niger MTCC
8189 using the tube dilution method (Cappucino and
Sherman, 1999). Dilutions of test (50–1.56 lg/mL) and stan-
dard compounds were prepared in double strength nutrient
broth––I.P. (bacteria) or Sabouraud dextrose broth I.P. (fungi)
(Pharmacopoeia of India, 2007). The samples were incubated
at 37 C for 24 h (bacteria), at 25 C for 7 d (A. niger), and
at 37 C for 48 h (C. albicans), and the results were recorded
in terms of minimum inhibitory concentration (MIC).
2.5. QSAR Studies
The structures of p-coumaric acid derivatives were ﬁrst pre-
optimized with the Molecular Mechanics Force Field
(MM+) procedure included in Hyperchem 6.0, 1993 and the
resulting geometries were further reﬁned by means of the semi-
empirical method PM3 (Parametric Method-3). We chose a
gradient norm limit of 0.01 kcal/A˚ for the geometry optimiza-
tion. The lowest energy structure was used for each molecule
to calculate physicochemical properties using TSAR 3.3 soft-
ware for Windows (TSAR 3D Version 3.3, 2000). Further,
the regression analysis was performed using the SPSS software
package (SPSS for Windows, 1999).
3. Results and discussion
3.1. Chemistry
p-Coumaric acid derivatives (1–36) were synthesized as out-
lined in Scheme 1. The physicochemical properties of the syn-
thesized compounds are presented in Table 1. The structures of
all the newly synthesized compounds were conﬁrmed by thePlease cite this article in press as: Khatkar, A. et al., Synthesis, antimic
Arabian Journal of Chemistry (2014), http://dx.doi.org/10.1016/j.arabjc.IR, 1H NMR and elemental analyses which were in full agree-
ment with their structures.
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Table 1 Physicochemical properties of synthesized p-coumaric acid derivatives (1–36).
Comp. Mol. formula M. Wt. m.p. (C) Rf Valuea % Yield
1 C15H12O3 240 170–172 0.71 52.2
2 C15H21NO2 247 102–104 0.67 47.5
3 C17H15NO3 281 189–191 0.87 43.3
4 C16H13NO3 267 213–215 0.57 67.6
5 C15H12N2O3 268 222–224 0.55 73.8
6 C15H11ClN2O4 318 198–200 0.84 63.2
7 C16H15NO3 269 175–177 0.77 58.1
8 C13H17NO4 251 94–96 0.91 81.9
9 C15H12N2O4 284 261–263 0.85 78.2
10 C12H14O3 206 148–150 0.52 66.7
11 C15H13NO3 255 267–269 0.42 76.4
12 C15H11Cl2NO2 308 194–196 0.57 82.1
13 C15H12N2O4 284 217–219 0.53 79.8
14 C16H14N2O4 298 179–181 0.63 72.2
15 C15H14N2O2 254 225–227 0.72 36.9
16 C17H25NO2 275 121–123 0.69 69.9
17 C18H13NO3 291 272–274 0.57 70.8
18 C15H18O3 246 193–195 0.83 80.4
19 C13H16O3 220 135–137 0.73 73.9
20 C19H26O3 302 211–213 0.97 61.7
21 C12H14O3 206 71–73 0.66 72.4
22 C16H14O3 254 255–257 0.68 75.6
23 C11H12O3 192 149–151 0.48 68.8
24 C10H10O3 178 103–105 0.76 81.4
25 C15H11NO5 285 265–267 0.43 77.9
26 C14H18O3 234 151–153 0.82 64.7
27 C15H12N2O4 284 237–239 0.81 73.8
28 C15H12ClNO2 273 187–189 0.68 77.1
29 C21H17NO2 315 281–283 0.89 69.3
30 C19H15NO2 289 265–267 0.66 58.9
31 C15H11ClN2O4 318 201–203 0.80 76.4
32 C15H12ClNO2 273 241–243 0.93 78.7
33 C15H13NO2 239 238–240 0.67 83.2
34 C13H15NO3 233 217–219 0.43 68.3
35 C11H13NO2 191 161–163 0.82 76.5
214–216 0.75 79.7
4 A. Khatkar et al.Compound 12. IR (ATR) cm1: 3620 (OAH str., phenol),
1708 (C‚O str., 20 amide), 3098 (CAH str., aromatic), 1539
(C‚C skeletal str., phenyl), 1643 (C‚C str., alkene), 753
(CACl str., C6H3Cl);
1H NMR (DMSO-d6, d ppm): 6.17–
7.29 (m, 7H, ArH), 7.38 {d, 1H, CH (C3), acryl}, 6.29 {d,
1H, CH (C2), acryl}, 7.72 (s, 1H, NH of amide); Anal. Calcu-
lated for C15H11Cl2NO2: C, 58.46; H, 3.60; N, 4.55; Found:
58.49; H, 3.64; N, 4.50.
Compound 14. IR (ATR) cm1: 1213 and 1411 (CAO str.,
and OAH in plane bending, phenol), 1691 (C‚O str., 20
amide), 3082 (CAH str., aromatic), 1507 (C‚C skeletal str.,
phenyl), 1627 (C‚C str., alkene), 1310 (NO2 sym. str.,
ArANO2), 2835 (CH3 str., ArACH3);
1H NMR (DMSO-d6,
d ppm): 6.68–7.87 (m, 7H, ArH), 7.44 {d, 1H, CH (C3), acryl},
6.97 {d, 1H, CH (C2), acryl}, 8.09 (s, 1H, NH of amide), 2.38
(s, 3H, aromatic CH3); Anal. Calculated for C16H14N2O4: C,
64.42; H, 4.73; N, 9.39; Found: C, 64.43; H, 4.78; N, 9.34.
Compound 17. IR (ATR) cm1: 3612 (OAH str., phenol),
1742 (C‚O str., ester), 3056 (CAH str., aromatic), 1544
(C‚C skeletal str., phenyl), 1638 (C‚C str., alkene), 1399
(ring str., quinoline), 752 (CAH out of plane bending,
quinoline), 1637 (C‚N str., quinoline) 1H NMR (DMSO-d6,
36 C17H17NO2 267
a TLC mobile phase: Benzene:Chloroform (7:3).Please cite this article in press as: Khatkar, A. et al., Synthesis, antimic
Arabian Journal of Chemistry (2014), http://dx.doi.org/10.1016/j.arabjc.d ppm): 7.52–8.03 (m, 10H, ArH), 7.98 {d, 1H, CH (C3),
acryl}, 7.28 {d, 1H, CH (C2), acryl}; Anal. Calculated for
C18H13NO3: C, 74.22; N, 4.81, H, 4.50; Found: C, 74.25; N,
4.77, H, 4.52.
Compound 22. IR (ATR) cm1: 3622 (OAH str., phenol),
1728 (C‚O str., ester), 2917 (CAH str., alkane), 3025 (CAH
str., aromatic), 1535 (C‚C skeletal str., phenyl), 1627 (C‚C
str., alkene); 1H NMR (DMSO-d6, d ppm): 6.98–7.76 (m,
9H, ArH), 7.98 {d, 1H, CH (C3), acryl}, 6.45 {d, 1H, CH
(C2), acryl}, 5.69 (s, 2H, benzyl); Anal. Calculated for
C16H14O3: C, 75.57; H, 5.55; Found: C, 75.52; H, 5.58.
Compound 25. IR (ATR) cm1: 1214 and 1464 (CAO str.,
and OAH in plane bending, phenol), 1740 (C‚O str., ester),
3038 (CAH str., aromatic), 1545 (C‚C skeletal str., phenyl),
1628 (C‚C str., alkene), 1338 (NO2 sym. str., ArANO2);
1H
NMR (DMSO-d6, d ppm): 6.93–8.12 (m, 8H, ArH), 7.45 {d,
1H, CH (C3), acryl}, 6.86 {d, 1H, CH (C2), acryl}; Anal. Cal-
culated for C15H11NO5: C, 63.16; H, 3.89; N, 4.91; Found: C,
63.19; H, 3.90; N, 4.88.
Compound 27. IR (ATR) cm1: 3649 (OAH str., phenol),
1690 (C‚O str., 20 amide), 3088 (CAH str., aromatic), 1525
(C‚C skeletal str., phenyl), 1622 (C‚C str., alkene), 1351robial evaluation and QSAR studies of p-coumaric acid derivatives.
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1H NMR (DMSO-d6, d ppm): 6.95–
7.39 (m, 8H, ArH), 7.34 {d, 1H, CH (C3), acryl}, 6.98 {d, 1H,
CH (C2), acryl}; Anal. Calculated for C15H12N2O4: C, 63.38;
H, 4.25; N, 9.85; Found: C, 63.42; H, 4.22; N, 9.81.
Compound 28. IR (ATR) cm1: 3650 (OAH str., phenol),
1693 (C‚O str., 20 amide), 3058 (CAH str., aromatic), 1544
(C‚C skeletal str., phenyl), 1647 (C‚C str., alkene), 690
(CACl str., C6H5Cl);
1H NMR (DMSO-d6, d ppm): 6.07–
7.52 (m, 8H, ArH), 7.50 {d, 1H, CH (C3), acryl}, 7.10 {d,
1H, CH (C2), acryl}, 7.62 (s, 1H, NH of amide); Anal. Calcu-
lated for C15H12ClNO2: C, 65.82; H, 4.42; N, 5.12; Found: C,
65.88; H, 4.41; N, 5.15.
Compound 30. IR (ATR) cm1: 3591 (OAH str., phenol),
1646 (C‚O str., 20 amide), 3063 (CAH str., aromatic), 1545
(C‚C skeletal str., phenyl), 1627 (C‚C str., alkene), 787
(CAH out of plane bending, 1-naphthalene), 1H NMR
(DMSO-d6, d ppm): 7.28–7.87 (m, 11H, ArH), 7.62 {d, 1H,
CH (C3), acryl}, 7.46 {d, 1H, CH (C2), acryl}, 8.02 (s, 1H,
NH of amide); Anal. Calculated for C19H15NO2: C, 78.87;
H, 5.23; N, 4.84; Found: C, 78.90; H, 5.22; N, 4.81.
Compound 33. IR (ATR) cm1: 3643 (OAH str., phenol),
1698 (C‚O str., 20 amide), 3083 (CAH str., aromatic), 1523
(C‚C skeletal str., phenyl), 1629 (C‚C str., alkene); 1H
NMR (DMSO-d6, d ppm): 7.03–7.32 (m, 9H, ArH), 7.29 {d,
1H, CH (C3), acryl}, 7.06 {d, 1H, CH (C2), acryl}, 9.57 (s,
1H, NH of amide); Anal. Calculated for C15H13NO2: C,
75.30; H, 5.48; N, 5.85; Found: C, 75.33; H, 5.52; N, 5.80.
Compound 34. IR (ATR) cm1: 3620 (OAH str., phenol),
1677 (C‚O str., 20 amide), 3029 (CAH str., aromatic), 1534
(C‚C skeletal str., phenyl), 1628 (C‚C str., alkene), 3468
(NAH str., morpholine), 2677 (CAH str., morpholine), 1103
(CAOAC str., morpholine); 1H NMR (DMSO-d6, d ppm):
6.97–8.10 (m, 4H, ArH), 7.92 {d, 1H, CH (C3), acryl}, 6.94
{d, 1H, CH (C2), acryl}, 2.82–3.78 (t, 8H, morpholine); Anal.
Calculated for C13H15NO3: C, 66.94; H, 6.48; N, 6.00; Found:
C, 66.96; H, 6.52; N, 5.96.3.2. In-vitro antimicrobial activity
Biological activity data determined as MIC values in lg/mL
were ﬁrst transformed into pMIC values (i.e. log MIC in
lM/mL) for the purpose of QSAR study. The synthesized
p-coumaric acid derivatives were evaluated for their in vitro
antibacterial activity against S. aureus, B. subtilis, E. coli and
antifungal activity against C. albicans and A. niger by the tube
dilution method. From the recorded pMIC values (Table 2), it
was observed that compounds 17 and 30 were found to be most
active against S. aureus having pMICsa value 1.67 lM/mL.
Compound 31 was found to be most potent against B. subtilis
having pMICbs value 2.01 lM/mL. Compounds 6 and 29 were
found to be most active against E. coli, having pMICec values
1.71 and 1.70 lM/mL respectively. In case of antifungal activ-
ity against C. albicans and A. niger, compound 17 was found to
be most active antifungal agent having pMICca and pMICan
values 1.67 and 1.97 lM/mL, respectively.
In general, the results of MBC/MFC studies revealed that
the synthesized compounds were bacteriostatic and fungistatic
in action as their MFC and MBC values were 3-fold higher
than their MIC values (a drug is considered to be bacterio-
static/fungistatic when its MFC and MBC values are 3-fold
higher than its MIC value) (Rodriguez-Arguelles et al., 2005).Please cite this article in press as: Khatkar, A. et al., Synthesis, antimic
Arabian Journal of Chemistry (2014), http://dx.doi.org/10.1016/j.arabjc.3.3. Structure–activity relationship
From the antimicrobial activity results of the synthesized
p-coumaric acid derivatives, the following structure–activity
relationship can be withdrawn:
 In case of antibacterial activity of synthesized p-coumaric
acid derivatives against S. aureus, esters and amides having
bulky aromatic groups increased the antibacterial potential
as evidenced by high antibacterial activity of compounds 17
and 30 (synthesized using 8-hydroxy quinoline and naph-
thylamine respectively).
 Results of antibacterial screening of synthesized p-coumaric
acid derivatives against B. subtilis indicated that anilides
having electron withdrawing substituents on phenyl nucleus
were found to be the most potent antibacterial agents as evi-
denced by the highest antibacterial activity of compound 31
(having 2-chloro-4-nitro substituents) against B. subtilis.
Role of electron withdrawing groups in improving antimi-
crobial activity is similar to the results of Sharma et al.
(2004).
 In case of antibacterial activity of p-coumaric acid deriva-
tives against E. coli, anilides having electron withdrawing
substituents on phenyl nucleus (6) and amides having bulky
aromatic substituents (29, having diphenyl) were found to
be the most potent antibacterial agents. The high antibacte-
rial activity of compounds having bulky aromatic substitu-
ents is in accordance with the results of Mahiwal et al.
(2012).
 Results of antifungal activity of p-coumaric acid derivatives
against C. albicans and A. niger indicated that ester deriva-
tive synthesized using 8-hydroxy quinoline (17) was found
to be the most potent one. The high antifungal activity of
8-hydroxy quinoline ester is supported by ﬁndings of
Sarova et al. (2011).
 From the above mentioned antimicrobial activity results, it
can be concluded that different structural requirements are
necessary for different p-coumaric acid derivatives to
become active against different microbial targets. This is in
accordance with the results obtained by Sortino et al. (2007).
The above mentioned ﬁndings are summarized in Fig. 1.
3.4. QSAR Studies
In order to identify the substituent effect on the antimicrobial
activity, quantitative structure–activity relationship (QSAR)
study was undertaken, using the linear free energy relationship
model (LFER) (Hansch and Fujita, 1964). Biological activities
in pMIC values are used as dependent variable in the QSAR
study. The different molecular descriptors (independent vari-
ables) selected for the present study are listed in Table 3.
The values of selected molecular descriptors used in the QSAR
study are presented in Table 4.
Our earlier studies (Kumar et al., 2012b; Judge et al.,
2012a,b; Narang et al., 2012a,b) indicated that the multi-target
QSAR (mt-QSAR) models are better than one-target QSAR
(ot-QSAR) models in describing the antimicrobial activity.
So, in the present study we have developed multi-target QSAR
models to describe the antimicrobial activity of synthesized p-
coumaric acid derivatives.robial evaluation and QSAR studies of p-coumaric acid derivatives.
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Table 2 Antimicrobial activity (pMIC in lM/mL) of synthesized p-coumaric acid derivatives against different microorganisms.
S. No. pMICec pMICsa pMICbs pMICan pMICca pMICab pMICaf pMICam
1 0.68 1.28 1.28 0.98 1.58 1.08 1.28 1.16
2 1.30 1.30 1.60 1.30 1.30 1.40 1.30 1.36
3 1.35 1.35 1.35 1.35 1.35 1.35 1.35 1.35
4 1.33 1.33 1.03 1.33 1.33 1.23 1.33 1.27
5 1.33 1.33 1.93 1.03 1.33 1.53 1.18 1.39
6 1.71 1.41 1.71 1.41 1.41 1.61 1.41 1.53
7 1.33 1.33 1.63 1.03 1.33 1.43 1.18 1.33
8 1.30 1.30 1.60 1.30 1.30 1.40 1.30 1.36
9 1.36 1.36 1.36 1.36 1.66 1.36 1.51 1.42
10 1.22 1.22 1.22 0.92 1.22 1.22 1.07 1.16
11 1.01 1.31 1.61 1.31 1.31 1.31 1.31 1.31
12 1.39 1.39 1.39 1.09 1.39 1.39 1.24 1.33
13 1.36 1.36 1.36 0.75 1.66 1.36 1.21 1.30
14 1.08 1.38 1.38 1.38 1.38 1.28 1.38 1.32
15 1.31 1.31 1.31 1.01 1.31 1.31 1.16 1.25
16 1.04 1.34 1.34 1.04 1.34 1.24 1.19 1.22
17 1.37 1.67 1.97 1.97 1.67 1.67 1.82 1.73
18 0.69 1.29 1.60 1.29 0.99 1.19 1.14 1.17
19 0.94 1.25 1.25 0.94 1.25 1.15 1.10 1.13
20 1.08 1.38 1.68 1.38 1.68 1.38 1.53 1.44
21 0.92 1.22 1.22 0.92 1.22 1.12 1.07 1.10
22 1.01 1.31 1.31 1.01 1.31 1.21 1.16 1.19
23 1.19 1.19 1.19 1.19 1.19 1.19 1.19 1.19
24 1.15 1.15 1.15 1.15 1.15 1.15 1.15 1.15
25 1.36 1.36 1.36 1.06 1.36 1.36 1.21 1.30
26 0.97 1.27 1.27 1.27 1.27 1.17 1.27 1.21
27 1.06 1.36 1.36 1.36 1.36 1.26 1.36 1.30
28 1.34 1.34 1.64 1.04 1.34 1.44 1.19 1.34
29 1.70 1.40 1.70 1.10 1.40 1.60 1.25 1.46
30 1.36 1.67 1.36 1.06 0.76 1.46 0.91 1.24
31 1.41 1.11 2.01 1.11 1.41 1.51 1.26 1.41
32 1.34 1.64 1.64 1.04 1.34 1.54 1.19 1.40
33 1.28 1.58 1.28 0.98 1.28 1.38 1.13 1.28
34 1.27 0.97 1.27 0.97 1.27 1.17 1.12 1.15
35 0.88 0.88 1.18 1.18 1.18 0.98 1.18 1.06
36 1.03 1.33 1.63 1.03 1.33 1.33 1.18 1.27
S.D. 0.22 0.21 0.28 0.23 0.27 0.19 0.20 0.16
Std. 2.61a 2.61a 2.61a 2.64b 2.64b – – –
S.D. = Standard deviation.
Std. = Standard.
a Norﬂoxacin.
b Fluconazole.
6 A. Khatkar et al.According to the ot-QSAR models, one should use ﬁve
different equations with different errors to predict the activity
of a new compound against ﬁve microbial species. However,
very recently the interest has been increased in the develop-
ment of multi-target QSAR (mt-QSAR) models. As opposed
to ot-QSAR, the mt-QSAR model is a single equation that
considers the nature of molecular descriptors which are
common and essential for describing the antibacterial and
antifungal activities (Gonzalez-Diaz et al., 2007, 2008; Cruz-
Monteagudo et al., 2007; Gonzalez-Diaz and Prado-Prado,
2008).
In light of above, we have attempted to develop three
different mt-QSAR models viz. mt-QSAR model for describing
antibacterial activity of synthesized compounds against
S. aureus, B. subtilis and E. coli, mt-QSAR model for describ-
ing antifungal activity against C. albicans and A. niger as well
as a common mt-QSAR model for describing the antimicrobial
(overall antibacterial and antifungal) activity.Please cite this article in press as: Khatkar, A. et al., Synthesis, antimic
Arabian Journal of Chemistry (2014), http://dx.doi.org/10.1016/j.arabjc.In order to developmt-QSARmodels, initially we calculated
the average antibacterial, antifungal and antimicrobial activities
of p-coumaric acid derivatives which are presented in Table 2.
During the regression analysis studies compounds 1, 17, 30
and 32 were designated as outliers and were not involved in the
data set for QSAR model generation. In multivariate statistics,
it is common to deﬁne three types of outliers (Furusjo et al.,
2006).
1. X/Y relation outliers are substances for which the relation-
ship between the descriptors (X variables) and the depen-
dent variables (Y variables) is not the same as in the (rest
of the) training data.
2. X outliers are substances whose molecular descriptors do
not lie in the same range as the (rest of the) training data.
3. Y outliers are only deﬁned for training or test samples.
They are substances for which the reference value of
response is invalid.robial evaluation and QSAR studies of p-coumaric acid derivatives.
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Figure 1 SAR of antimicrobial activity of synthesized p-coumaric acid derivatives.
Table 3 QSAR descriptors used in the study.
S. No. QSAR descriptor Type
1 log P Lipophilic
2 Zero order molecular connectivity index (0v) Topological
3 First order molecular connectivity index (1v) Topological
4 Second order molecular connectivity index (2v) Topological
5 Valence zero order molecular connectivity index (0vv) Topological
6 Valence ﬁrst order molecular connectivity index (1vv) Topological
7 Valence second order molecular connectivity index (2vv) Topological
8 Kier’s alpha ﬁrst order shape index (ja1) Topological
9 Kier’s alpha second order shape index (ja2) Topological
10 Kier’s ﬁrst order shape index (j1) Topological
11 Randic topological index Topological
12 Balaban topological index Topological
13 Wiener’s topological index Topological
14 Kier’s second order shape index (j2) Topological
15 Ionization potential Electronic
16 Dipole moment (l) Electronic
17 Energy of the highest occupied molecular orbital (HOMO) Electronic
18 Energy of the lowest unoccupied molecular orbital (LUMO) Electronic
19 Total energy (Te) Electronic
20 Nuclear energy (Nu. E) Electronic
21 Molar refractivity (MR) Steric
Synthesis, antimicrobial evaluation and QSAR studies of p-coumaric acid derivatives 7As there was no difference in the activity (Table 2) as well
as the molecular descriptor range (Table 4) of these outliers
when compared to the other p-coumaric acid derivatives, these
outliers belong to the category of Y outliers (substances for
which the reference value of response is invalid) (Furusjo
et al., 2006).
Preliminary analysis was carried out in terms of correlation
analysis. A correlation matrix constructed for antibacterial
activity of the synthesized compounds is presented in Table 5.
In general, high collinearity (r> 0.5) was observed between
different parameters. The high interrelationship was observed
between topological parameters, Wiener index and ﬁrst orderPlease cite this article in press as: Khatkar, A. et al., Synthesis, antimic
Arabian Journal of Chemistry (2014), http://dx.doi.org/10.1016/j.arabjc.molecular connectivity index (1v) (r= 0.987) and low interre-
lationship was observed between electronic parameter, energy
of the highest occupied molecular orbital (HOMO) and topo-
logical parameter, ﬁrst order molecular connectivity index (1v)
(r= 0.023). Correlation of calculated molecular descriptors
with antibacterial, antifungal and antimicrobial activities is
presented in Table 5.
The structural effects on variations in antibacterial activity
of the synthesized p-coumaric acid derivatives in terms of
pMICab (log MICab) were examined by regression analysis
with molecular parameters. For 32 p-coumaric acid deriva-
tives, Eq. (1) was derived as that of the best quality usingrobial evaluation and QSAR studies of p-coumaric acid derivatives.
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Table 4 Values of selected parameters used in QSAR studies of synthesized p-coumaric acid derivatives.
Comp. log P MR 0v 1v j1 ja1 W Ee LUMO HOMO l
1 3.58 69.30 12.79 8.74 14.41 12.23 724.00 16965.10 0.77 9.10 2.37
2 3.25 74.55 13.22 8.72 16.06 14.61 804.00 18409.30 0.52 8.92 4.59
3 2.93 80.82 15.24 10.08 17.36 14.84 1010.00 22723.90 0.77 9.08 3.91
4 2.91 76.31 14.37 9.65 16.37 13.86 967.00 19761.90 0.73 9.07 5.03
5 2.07 74.13 14.37 9.65 16.37 14.18 967.00 19866.10 0.80 9.11 3.82
6 3.40 83.38 16.11 10.45 18.34 16.00 1259.00 23739.00 1.17 9.30 9.89
7 2.68 77.71 14.37 9.69 16.37 14.15 943.00 20583.80 0.61 8.45 4.01
8 0.61 68.95 13.38 8.67 16.06 14.53 705.00 20007.40 0.48 8.92 3.45
9 2.89 78.58 15.24 10.06 17.36 14.73 1064.00 22338.70 1.08 9.12 4.44
10 2.71 58.80 11.10 7.22 13.07 11.62 446.00 14075.60 0.70 9.04 2.61
11 2.80 74.00 13.66 9.13 15.39 13.17 848.00 18620.20 0.71 8.49 0.78
12 3.97 80.86 14.54 9.54 16.37 14.75 963.00 20217.50 0.85 8.84 4.78
13 2.89 78.58 15.24 10.04 17.36 14.73 1136.00 21635.90 1.14 9.26 9.64
14 3.35 83.62 16.11 10.45 18.34 15.71 1217.00 23950.50 0.98 9.15 10.11
15 2.15 75.95 13.66 9.15 15.39 13.17 824.00 19156.60 0.57 8.60 4.69
16 3.91 84.12 14.79 9.67 18.05 16.60 955.00 22846.90 0.42 8.91 3.90
17 3.67 83.22 15.36 10.72 16.84 14.51 1194.00 22650.90 0.74 8.96 1.79
18 3.49 70.54 12.79 8.74 14.41 12.99 724.00 18808.60 0.67 9.02 1.26
19 3.11 63.40 11.80 7.72 14.06 12.62 549.00 15475.40 0.70 9.04 2.71
20 4.95 88.71 16.11 10.45 18.34 16.91 1193.00 27434.80 0.68 9.03 2.61
21 2.66 58.69 11.26 7.08 13.07 11.62 434.00 14310.10 0.67 9.03 2.52
22 3.68 74.14 13.50 9.24 15.39 13.21 872.00 18462.20 0.73 9.08 2.60
23 2.24 54.27 10.39 6.72 12.07 10.63 358.00 12694.60 0.70 9.04 2.69
24 1.90 49.52 9.68 6.22 11.08 9.64 284.00 11313.80 0.72 9.06 2.59
25 3.54 76.63 15.24 10.04 17.36 14.73 1136.00 21867.50 1.21 9.35 8.55
26 3.11 63.40 11.80 7.72 14.06 12.62 549.00 15475.40 0.70 9.04 2.71
27 2.89 78.58 15.24 10.04 17.36 14.73 1100.00 21758.10 0.99 9.19 5.79
28 3.45 76.06 13.66 9.13 15.39 13.49 848.00 18392.00 0.79 8.70 4.99
29 4.86 95.92 16.78 11.74 18.78 15.87 1405.00 26475.00 0.59 8.61 3.98
30 3.93 87.70 15.36 10.72 16.84 14.20 1194.00 22257.40 0.70 8.28 2.37
31 3.40 83.38 16.11 10.45 18.34 16.00 1250.00 23778.40 1.27 9.29 9.10
32 3.45 76.06 13.66 9.13 15.39 13.49 836.00 18492.30 0.77 8.84 5.35
33 2.93 71.25 12.79 8.74 14.41 12.23 724.00 16765.20 0.69 8.66 4.01
34 1.15 65.44 12.09 8.25 13.43 11.98 594.00 17550.30 0.52 9.00 2.99
35 1.50 56.37 10.55 6.59 12.07 10.63 347.00 12791.70 0.49 8.92 4.02
36 3.87 81.33 14.54 9.54 16.37 14.18 952.00 20229.00 0.67 8.45 4.07
Table 5 Correlation matrix for the antibacterial activity of synthesized p-coumaric acid derivatives.
pMICab log P
0vv 1v j1 ja1 W Ee LUMO HOMO l
pMICab 1.000
log P 0.365 1.000
0vv 0.675 0.712 1.000
1v 0.753 0.580 0.918 1.000
j1 0.721 0.570 0.935 0.963 1.000
ja1 0.688 0.589 0.955 0.908 0.977 1.000
W 0.752 0.601 0.909 0.987 0.969 0.913 1.000
Ee 0.695 0.578 0.954 0.961 0.968 0.956 0.955 1.000
LUMO 0.381 0.238 0.251 0.430 0.439 0.345 0.528 0.366 1.000
HOMO 0.084 0.049 0.040 0.023 0.123 0.127 0.114 0.089 0.607 1.000
l 0.440 0.160 0.406 0.521 0.580 0.511 0.613 0.484 0.740 0.466 1.000
8 A. Khatkar et al.the topological parameter, ﬁrst order molecular connectivity
index (1v, r= 0.753, Table 4).
3.4.1. LR mt-QSAR model for antibacterial activity
pMICab ¼ 0:08191vþ 0:569 ð1Þ
n ¼ 32 r ¼ 0:753 q2 ¼ 0:508 s ¼ 0:096 F ¼ 39:25Please cite this article in press as: Khatkar, A. et al., Synthesis, antimic
Arabian Journal of Chemistry (2014), http://dx.doi.org/10.1016/j.arabjc.Here and thereafter, n – number of data points, r – correla-
tion coefﬁcient, q2 – cross validated r2 obtained by leave one
out method, s – standard error of the estimate and F - Fischer
statistics.
Coefﬁcient of 1v in Eq. (1) is positive which indicates that
antibacterial activity of synthesized compounds is positively
correlated to ﬁrst order molecular connectivity index (1v) i.e.
antibacterial activity of synthesized compounds will increaserobial evaluation and QSAR studies of p-coumaric acid derivatives.
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Synthesis, antimicrobial evaluation and QSAR studies of p-coumaric acid derivatives 9with increase in the value of 1v and vice versa. This is
evidenced by antibacterial activity data of synthesized com-
pounds (Table 2) and their 1v values (Table 3) i.e. compounds
6, 17 and 29 having high 1v values of 10.45, 10.72 and 11.74 are
having high antibacterial activity (pMICab = 1.61, 1.67 and
1.60 lM/mL ,respectively).
The molecular connectivity index, an adjacency based topo-
logical index proposed by Randic is denoted by v and is
deﬁned as sum of over all the edges (ij) as per following
v ¼
Xn
i¼1
ðViVjÞ1=2
where Vi and Vj are the degrees of adjacent vertices i and j and
n is the number of vertices in a hydrogen suppressed molecular
structure (Lather and Madan, 2005). The topological index, v
signiﬁes the degree of branching, connectivity of atoms and
unsaturation in the molecule which accounts for variation in
activity.
The QSAR model expressed by Eq. (1) was cross validated
by its high q2 value (q2 = 0.508) obtained by the leave one out
(LOO) method. The value of q2 greater than 0.5 is the basic
requirement for qualifying a QSAR model to be valid one
(Golbraikh and Tropsha, 2002). As the observed and predicted
antibacterial activity values are close to each other (Table 7),
the mt-QSAR model for antibacterial activity (Eq. (1)) is a
valid one. The plot of predicted pMICab against observed
pMICab (Fig. 2) also favours the developed QSAR model
expressed by Eq. (2). Further, the plot of observed pMICabTable 6 Correlation of antibacterial (pMICab), antifungal
(pMICaf) and antimicrobial (pMICam) activities of synthesized
p-coumaric acid derivatives with calculated molecular
descriptors.
Descriptor pMICab pMICaf pMICam
Cos E 0.355 0.168 0.341
log P 0.365 0.291 0.399
MR 0.722 0.551 0.780
0v 0.737 0.626 0.822
0vv 0.675 0.573 0.753
1v 0.753 0.569 0.811
1vv 0.621 0.522 0.690
2v 0.715 0.592 0.791
2vv 0.557 0.557 0.656
3v 0.495 0.589 0.621
3vv 0.358 0.536 0.495
j1 0.721 0.636 0.815
j2 0.590 0.460 0.641
j3 0.253 0.243 0.294
ja1 0.688 0.633 0.788
ja2 0.474 0.388 0.523
ja3 0.137 0.163 0.172
R 0.753 0.569 0.811
J 0.471 0.186 0.437
W 0.752 0.600 0.823
Te 0.732 0.630 0.820
Ele. E 0.695 0.654 0.801
Nu. E 0.681 0.649 0.789
SA 0.599 0.539 0.681
IP 0.084 0.239 0.035
LUMO 0.381 0.358 0.439
HOMO 0.084 0.239 0.035
l 0.440 0.310 0.465
Please cite this article in press as: Khatkar, A. et al., Synthesis, antimic
Arabian Journal of Chemistry (2014), http://dx.doi.org/10.1016/j.arabjc.vs. residual pMICab (Fig. 3) indicated that there was no sys-
temic error in model development as the propagation of error
was observed on both sides of zero (Kumar et al., 2007).
Results of correlation of calculated molecular descriptors
with antifungal activity of synthesized compounds (Table 5)
indicated that electronic parameter, electronic energy (Ee)
was the most dominating descriptor for antifungal activity of
synthesized compounds. So, QSAR model for antifungal activ-
ity of synthesized p-coumaric acid derivatives was developed
by using the electronic parameter, electronic energy (Ee)
(r= 0.654, Table 5, Eq. (2)).
3.4.2. LR mt-QSAR model for antifungal activity
pMICaf ¼ 0:0000192Eeþ 0:865 ð2Þ
n ¼ 32 r ¼ 0:654 q2 ¼ 0:334 s ¼ 0:089 F ¼ 22:39
The coefﬁcient of Ee in Eq. (2) is negative which indicates
that antifungal activity of synthesized compounds is negativelyObserved pMICab
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Figure 2 Plot of observed pMICab against predicted pMICab
obtained by Eq. (1).
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Figure 3 Plot of observed pMICab against residual pMICab
obtained by Eq. (1).
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Table 7 Comparison of observed, predicted and residual antimicrobial activities obtained by mt-QSAR models.
Comp. pMICab pMICaf pMICam
Obs Pre Res Obs Pre Res Obs Pre Res
1 1.08 1.28 0.20 1.28 1.19 0.09 1.16 1.24 0.08
2 1.40 1.28 0.12 1.30 1.22 0.08 1.36 1.27 0.09
3 1.35 1.39 0.04 1.35 1.30 0.05 1.35 1.33 0.02
4 1.23 1.36 0.13 1.33 1.24 0.09 1.27 1.32 0.05
5 1.53 1.36 0.17 1.18 1.25 0.07 1.39 1.32 0.07
6 1.61 1.43 0.18 1.41 1.32 0.09 1.53 1.41 0.12
7 1.43 1.36 0.07 1.18 1.26 0.08 1.33 1.31 0.02
8 1.40 1.28 0.12 1.30 1.25 0.05 1.36 1.24 0.12
9 1.36 1.39 0.03 1.51 1.29 0.22 1.42 1.35 0.07
10 1.22 1.16 0.06 1.07 1.14 0.07 1.16 1.16 0.00
11 1.31 1.32 0.01 1.31 1.22 0.09 1.31 1.28 0.03
12 1.39 1.35 0.04 1.24 1.25 0.01 1.33 1.32 0.01
13 1.36 1.39 0.03 1.21 1.28 0.07 1.30 1.37 0.07
14 1.28 1.43 0.15 1.38 1.32 0.06 1.32 1.40 0.08
15 1.31 1.32 0.01 1.16 1.23 0.07 1.25 1.27 0.02
16 1.24 1.36 0.12 1.19 1.30 0.11 1.22 1.31 0.09
17 1.67 1.45 0.22 1.82 1.30 0.52 1.73 1.39 0.34
18 1.19 1.28 0.09 1.14 1.23 0.09 1.17 1.24 0.07
19 1.15 1.20 0.05 1.10 1.16 0.06 1.13 1.19 0.06
20 1.38 1.43 0.05 1.53 1.39 0.14 1.44 1.39 0.05
21 1.12 1.15 0.03 1.07 1.14 0.07 1.10 1.15 0.05
22 1.21 1.33 0.12 1.16 1.22 0.06 1.19 1.29 0.10
23 1.19 1.12 0.07 1.19 1.11 0.08 1.19 1.13 0.06
24 1.15 1.08 0.07 1.15 1.08 0.07 1.15 1.10 0.05
25 1.36 1.39 0.03 1.21 1.28 0.07 1.30 1.37 0.07
26 1.17 1.20 0.03 1.27 1.16 0.11 1.21 1.19 0.02
27 1.26 1.39 0.13 1.36 1.28 0.08 1.30 1.36 0.06
28 1.44 1.32 0.12 1.19 1.22 0.03 1.34 1.28 0.06
29 1.60 1.53 0.07 1.25 1.37 0.12 1.46 1.45 0.01
30 1.46 1.45 0.01 0.91 1.29 0.38 1.24 1.39 0.15
31 1.51 1.43 0.08 1.26 1.32 0.06 1.41 1.41 0.00
32 1.54 1.32 0.22 1.19 1.22 0.03 1.40 1.28 0.12
33 1.38 1.28 0.10 1.13 1.19 0.06 1.28 1.24 0.04
34 1.17 1.25 0.08 1.12 1.20 0.08 1.15 1.20 0.05
35 0.98 1.11 0.13 1.18 1.11 0.07 1.06 1.12 0.06
36 1.33 1.35 0.02 1.18 1.25 0.07 1.27 1.31 0.04
10 A. Khatkar et al.correlated to electronic parameter, electronic energy (Ee) i.e.
antifungal activity of synthesized compounds will increase with
decrease in the value of Ee and vice versa (Tables 2 and 3).
The validity and predictability of the QSAR model for anti-
fungal activity i.e. Eq. (2) were cross validated by q2 value
(q2 = 0.334) obtained by the leave one out (LOO) method.
The value of q2 less than 0.5 indicated that the developed
model is an invalid one. But one should not forget the recom-
mendations of Golbraikh and Tropsha (2002) who reported
that the only way to estimate the true predictive power of a
model is to test its ability to predict accurately the biological
activities of compounds. As the observed and predicted values
are close to each other (Table 6), the mt-QSAR model for anti-
fungal activity (Eq. (2)) is therefore a valid one.
The mt-QSAR model of antimicrobial activity (Eq. (3))
depicted the importance of topological parameter, Wiener
index (W) in describing antimicrobial activity of synthesized
compounds (Table 5).
3.4.3. LR mt-QSAR model for antimicrobial activity
pMICam ¼ 0:000312Wþ 1:016 ð3ÞPlease cite this article in press as: Khatkar, A. et al., Synthesis, antimic
Arabian Journal of Chemistry (2014), http://dx.doi.org/10.1016/j.arabjc.n ¼ 32 r ¼ 0:823 q2 ¼ 0:635 s ¼ 0:065 F ¼ 62:98
As in case of antibacterial activity, coefﬁcient of W in
Eq. (3) is positive which indicates that antimicrobial activity
of synthesized compounds is positively correlated to Wiener
index (W) i.e. antimicrobial activity of synthesized compounds
will increase with increase in the value of W. This is evidenced
by the antimicrobial activity data of synthesized compounds
(Table 2) and their W values (Table 3).
The Wiener index W=W(G) of G is deﬁned as the half
sum of the elements of the distance matrix.
W ¼WðGÞ ¼ 1=2
X
i¼1;j¼1
ðDÞij
where (Dij) is the ijth element of the distance matrix which
denotes the shortest graph–theoretical distance between sites
i and j of G (Wiener, 1947).
The QSAR models expressed by Eq. (3) were cross vali-
dated by its high q2 values (q2 = 0.635) obtained by the leave
one out (LOO) method. The value of q2 greater than 0.5 is the
basic requirement for qualifying a QSAR model to be valid
one (Golbraikh and Tropsha, 2002). As the observed androbial evaluation and QSAR studies of p-coumaric acid derivatives.
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Figure 4 Plot of observed pMICam against predicted pMICam
obtained by Eq. (3).
Synthesis, antimicrobial evaluation and QSAR studies of p-coumaric acid derivatives 11predicted antimicrobial activity values are close to each other
(Table 6), the mt-QSAR model for antimicrobial activity
(Eq. (3)) is a valid one. The plot of predicted pMICam against
observed pMICam (Fig. 4) also favours the developed model
expressed by Eq. (3). Further, the plot of observed pMICam
vs. residual pMICam (Fig. 5) indicated that there was no sys-
temic error in model development as the propagation of error
was observed on both sides of zero (Kumar et al., 2007). Fur-
ther, high residual values (Table 6) observed in case of outliers
also justiﬁed their removal before the development of QSAR
models.
It was observed from mt-QSAR models (Eqs. (1)–(3)) that
the antibacterial, antifungal and overall antimicrobial activi-
ties of synthesized p-coumaric acid derivatives were governed
by the topological parameters, Wiener index (W) and ﬁrst
order molecular connectivity index (1v) as well as electronic
parameter, electronic energy (Ee).
Generally for QSAR studies, the biological activities of
compounds should span 2–3 orders of magnitude. But in the
present study the range of antimicrobial activities of theObserbved pMICam
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Figure 5 Plot of observed pMICam against residual pMICam
obtained by Eq. (3).
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is in accordance with results suggested by Bajaj et al. who
stated that the reliability of the QSAR model lies in its predic-
tive ability even though the activity data are in the narrow
range (Bajaj et al., 2005). When biological activity data lie in
the narrow range, the presence of minimum standard deviation
of the biological activity justiﬁes its use in QSAR studies
(Narasimhan et al., 2007). The minimum standard deviation
(Table 2) observed in the antimicrobial activity data justiﬁes
its use in QSAR studies.
4. Conclusion
A series of p-coumaric acid derivatives (1–36) was synthesized
and evaluated in vitro for their antimicrobial activity by the
tube dilution method. Results of antimicrobial screening
indicated that esters and amides of p-coumaric acid having
bulky aromatic groups and anilides having electron withdraw-
ing substituents were more potent than other members of the
series. Results of MBC/MFC studies indicated that the synthe-
sized compounds were bacteriostatic and fungistatic in action.
The results of QSAR studies demonstrated that antibacterial,
antifungal and overall antimicrobial activities of synthesized
p-coumaric acid derivatives were governed by the electronic
parameter, electronic energy (Ee) and topological parameters
ﬁrst order molecular connectivity index (1v) and Wiener index
(W).
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